P. Alter and B. Maisch, Endomyocardial fibrosis in Churg???Strauss syndrome assessed by cardiac magnetic resonance imaging, International Journal of Cardiology, vol.108, issue.1, pp.112-113, 2006.
DOI : 10.1016/j.ijcard.2005.02.019

A. Amano, N. Sakai, N. Higashi, Y. Yoshizawa, and S. Kawana, A Case of Hypereosinophilic Syndrome, The Journal of Dermatology, vol.46, issue.4, pp.286-289, 2005.
DOI : 10.1111/j.1346-8138.2005.tb00764.x

C. Frances, Specific mucosal erosions in hypereosinophilic syndrome. Evidence for eosinophil protein deposition, Arch Dermatol, vol.132, pp.535-541, 1996.

B. Bain, Hypereosinophilia, Current Opinion in Hematology, vol.7, issue.1, pp.21-25, 2000.
DOI : 10.1097/00062752-200001000-00005

F. Ballanger, S. Barbarot, and M. Hamidou, Syndromes hyper??osinophiliques primitifs : actualit??s, Annales de Dermatologie et de V??n??r??ologie, vol.133, issue.5, pp.1487-1494, 2006.
DOI : 10.1016/S0151-9638(06)70947-4

R. Barouky, L. Bencharif, F. Badet, G. Salles, V. Durand et al., Mucosal ulcerations revealing primitive hypereosinophilic syndrome, Eur J Dermatol, vol.13, pp.207-208, 2003.

C. Billon, C. Gautier, E. Villaret, M. Ducos, J. Martin et al., [Isolated mucosal ulcers disclosing idiopathic hypereosinophilic syndrome], Ann Dermatol Venereol, vol.124, pp.248-250, 1997.

D. Broide, M. Paine, and G. Firestein, Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics., Journal of Clinical Investigation, vol.90, issue.4, pp.1414-1424, 1992.
DOI : 10.1172/JCI116008

J. Butterfield, Interferon Treatment for Hypereosinophilic Syndromes and Systemic Mastocytosis, Acta Haematologica, vol.114, issue.1, pp.26-40, 2005.
DOI : 10.1159/000085560

M. Chusid, D. Dale, B. West, and S. Wolff, THE HYPEREOSINOPHILIC SYNDROME, Medicine, vol.54, issue.1, pp.1-27, 1975.
DOI : 10.1097/00005792-197501000-00001

E. Clutterbuck and C. Sanderson, Regulation of human eosinophil precursor production by cytokines: a comparison of recombinant human interleukin-1 (rhIL-1), rhIL-3, rhIL-5, rhIL-6, and rh granulocyte-macrophage colony-stimulating factor, Blood, vol.75, pp.1774-1779, 1990.

E. Cogan, L. Schandene, A. Crusiaux, P. Cochaux, T. Velu et al., Clonal Proliferation of Type 2 Helper T Cells in a Man with the Hypereosinophilic Syndrome, New England Journal of Medicine, vol.330, issue.8, pp.535-538, 1994.
DOI : 10.1056/NEJM199402243300804

P. Collins, S. Marleau, D. Griffiths-johnson, P. Jose, and T. Williams, Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo, Journal of Experimental Medicine, vol.182, issue.4, pp.1169-1174, 1995.
DOI : 10.1084/jem.182.4.1169

J. Colombel, A. Janin, and G. Torpier, Activated eosinophils in coeliac disease., Gut, vol.31, issue.5, pp.583-584, 1990.
DOI : 10.1136/gut.31.5.583

J. Cools, D. Deangelo, J. Gotlib, E. Stover, R. Legare et al., Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome, New England Journal of Medicine, vol.348, issue.13, pp.1201-1214, 2003.
DOI : 10.1056/NEJMoa025217

M. Daneshpouy, T. Facon, J. Jouet, and A. Janin, Acute Flare-up of Conjunctival Graft-versus-host Disease with Eosinophil Infiltration in a Patient with Chronic Graft-versus-host Disease, Leukemia & Lymphoma, vol.33, issue.2, pp.445-446, 2002.
DOI : 10.1080/10428190290006323

M. Daneshpouy, G. Socie, M. Lemann, J. Rivet, E. Gluckman et al., Activated eosinophils in upper gastrointestinal tract of patients with graft-versus-host disease, Blood, vol.99, issue.8, pp.3033-3040, 2002.
DOI : 10.1182/blood.V99.8.3033

M. Ricci and S. Romagnani, Defective in vitro production of gamma-interferon and tumor necrosis factor-alpha by circulating T cells from patients with the hyper-immunoglobulin E syndrome, J Clin Invest, vol.84, pp.1830-1835, 1989.

P. Desreumaux, E. Delaporte, J. Colombel, M. Capron, A. Cortot et al., Similar IL-5, IL-3, and GM-CSF Syntheses by Eosinophils in the Jejunal Mucosa of Patients with Celiac Disease and Dermatitis Herpetiformis, Clinical Immunology and Immunopathology, vol.88, issue.1, pp.14-21, 1998.
DOI : 10.1006/clin.1997.4494

P. Desreumaux, A. Janin, J. Colombel, L. Prin, J. Plumas et al., Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease, Journal of Experimental Medicine, vol.175, issue.1, pp.293-296, 1992.
DOI : 10.1084/jem.175.1.293

P. Desreumaux, A. Janin, E. Delaporte, S. Dubucquoi, F. Piette et al., Parallel interleukin 5 synthesis by eosinophils in duodenal and skin lesions of a patient with dermatitis herpetiformis., Gut, vol.37, issue.1, pp.132-135, 1995.
DOI : 10.1136/gut.37.1.132

P. Desreumaux, A. Janin, S. Dubucquoi, M. Copin, G. Torpier et al., Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases, Blood, vol.82, pp.1553-1560, 1993.

B. Druker, M. Talpaz, D. Resta, B. Peng, E. Buchdunger et al., Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia, New England Journal of Medicine, vol.344, issue.14, pp.1031-1037, 2001.
DOI : 10.1056/NEJM200104053441401

S. Dubucquoi, A. Janin, P. Desreumaux, J. Rigot, M. Copin et al., Evidence for eosinophil activation in eosinophilic cystitis, Eur Urol, vol.25, pp.254-258, 1994.

S. Dubucquoi, A. Janin, O. Klein, P. Desreumaux, P. Quandalle et al., Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease., Gut, vol.37, issue.2, pp.242-246, 1995.
DOI : 10.1136/gut.37.2.242

A. Fauci, J. Harley, W. Roberts, V. Ferrans, H. Gralnick et al., The Idiopathic Hypereosinophilic Syndrome, Annals of Internal Medicine, vol.97, issue.1, pp.78-92, 1982.
DOI : 10.7326/0003-4819-97-1-78

T. Fukushima, K. Kuriyama, H. Ito, Y. Miyazaki, K. Arimura et al., Successful bone marrow transplantation for idiopathic hypereosinophilic syndrome, British Journal of Haematology, vol.113, issue.1, pp.213-215, 1995.
DOI : 10.1097/00005792-197501000-00001

J. Garrett, S. Jameson, B. Thomson, M. Collins, L. Wagoner et al., Anti???interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes???, Journal of Allergy and Clinical Immunology, vol.113, issue.1, pp.115-119, 2004.
DOI : 10.1016/j.jaci.2003.10.049

C. Genton, Y. Wang, S. Izui, B. Malissen, G. Delsol et al., The Th2 Lymphoproliferation Developing in LatY136F Mutant Mice Triggers Polyclonal B Cell Activation and Systemic Autoimmunity, The Journal of Immunology, vol.177, issue.4, pp.2285-2293, 2006.
DOI : 10.4049/jimmunol.177.4.2285
URL : https://hal.archives-ouvertes.fr/hal-00165594

G. Gleich and K. Leiferman, The hypereosinophilic syndromes: still more heterogeneity, Current Opinion in Immunology, vol.17, issue.6, 2005.
DOI : 10.1016/j.coi.2005.09.008

G. Gleich, K. Leiferman, A. Pardanani, A. Tefferi, and J. Butterfield, Treatment of hypereosinophilic syndrome with imatinib mesilate, The Lancet, vol.359, issue.9317, pp.1577-1578, 2002.
DOI : 10.1016/S0140-6736(02)08505-7

J. Gotlib, Molecular classification and pathogenesis of eosinophilic disorders, update, 2005.

J. Gotlib, J. Cools, J. Malone, S. Schrier, D. Gilliland et al., The FIP1L1-PDGFR?? fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management, Blood, vol.103, issue.8, pp.2879-2891, 2004.
DOI : 10.1182/blood-2003-06-1824

B. Granel, J. Serratrice, L. Swiader, N. Horshowski, D. Blaise et al., Lymphomatoid papulosis associated with both severe hypereosinophilic syndrome and CD30 positive large T-cell lymphoma, Cancer, vol.27, issue.10, pp.2138-2143, 2000.
DOI : 10.1002/1097-0142(20001115)89:10<2138::AID-CNCR15>3.0.CO;2-W

J. Griffin, J. Leung, R. Bruner, M. Caligiuri, and R. Briesewitz, Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome, Proceedings of the National Academy of Sciences, vol.100, issue.13, pp.7830-7835, 2003.
DOI : 10.1073/pnas.0932698100

W. Hardy and R. Anderson, The Hypereosinophilic Syndromes, Annals of Internal Medicine, vol.68, issue.6, pp.1220-1229, 1968.
DOI : 10.7326/0003-4819-68-6-1220

S. Hofmann, K. Technau, A. Muller, M. Lubbert, and L. Bruckner-tuderman, Bullous pemphigoid associated with hypereosinophilic syndrome: Simultaneous response to imatinib, Journal of the American Academy of Dermatology, vol.56, issue.5, pp.68-72, 2007.
DOI : 10.1016/j.jaad.2006.02.059

M. Huntgeburth, M. Lindner, J. Fries, and U. Hoppe, Hypereosinophiles Syndrom mit akut nekrotisierender Myokarditis und Kardiomyopathie, Zeitschrift f??r Kardiologie, vol.108, issue.11, pp.761-766, 2005.
DOI : 10.1007/s00392-005-0288-0

M. Ionescu, J. Rivet, M. Daneshpouy, J. Briere, P. Morel et al., In situ eosinophil activation in 26 primary cutaneous T-cell lymphomas with blood eosinophilia, Journal of the American Academy of Dermatology, vol.52, issue.1, pp.32-39, 2005.
DOI : 10.1016/j.jaad.2004.03.003

E. Jabbour, S. Verstovsek, F. Giles, V. Gandhi, J. Cortes et al., 2-Chlorodeoxyadenosine and cytarabine combination therapy for idiopathic hypereosinophilic syndrome, Cancer, vol.102, issue.3, pp.541-546, 2005.
DOI : 10.1002/cncr.21186

A. Janin, Eosinophilic myocarditis and fibrosis, Human Pathology, vol.36, issue.5, pp.592-593, 2005.
DOI : 10.1016/j.humpath.2005.03.001

A. Janin, M. Copin, J. Dubos, V. Rouland, E. Delaporte et al., Familial peeling skin syndrome with eosinophilia: clinical, histologic, and ultrastructural study of three cases, Arch Pathol Lab Med, vol.120, pp.662-665, 1996.

A. Janin, G. Socie, A. Devergie, S. Aractingi, H. Esperou et al., Fasciitis in Chronic Graft-versus-Host Disease: A Clinicopathologic Study of 14 Cases, Annals of Internal Medicine, vol.120, issue.12, pp.993-998, 1994.
DOI : 10.7326/0003-4819-120-12-199406150-00004

A. Janin, G. Torpier, M. Capron, P. Courtin, and B. Gosselin, Immunopathological study of eosinophils in eosinophilic granuloma of bone: Evidence for release of three cationic proteins and subsequent uptake in macrophages, Virchows Archiv A Pathological Anatomy and Histopathology, vol.163, issue.3, pp.255-261, 1992.
DOI : 10.1007/BF01611183

E. Jong, A. Mahmoud, and S. Klebanoff, Peroxidase-mediated toxicity to schistosomula of Schistosoma mansoni, J Immunol, vol.126, pp.468-471, 1981.

A. Lorentz, S. Schwengberg, C. Mierke, M. Manns, and S. Bischoff, Human intestinal mast cells produce IL-5in vitro upon IgE receptor cross-linking andin vivo in the course of intestinal inflammatory disease, European Journal of Immunology, vol.175, issue.5, pp.1496-1503, 1999.
DOI : 10.1002/(SICI)1521-4141(199905)29:05<1496::AID-IMMU1496>3.0.CO;2-5

A. Matthews, D. Friend, N. Zimmermann, M. Sarafi, A. Luster et al., Eotaxin is required for the baseline level of tissue eosinophils, Proceedings of the National Academy of Sciences, vol.95, issue.11, pp.6273-6278, 1998.
DOI : 10.1073/pnas.95.11.6273

A. Mishra, S. Hogan, J. Lee, P. Foster, and M. Rothenberg, Fundamental signals that regulate eosinophil homing to the gastrointestinal tract, Journal of Clinical Investigation, vol.103, issue.12, pp.1719-1727, 1999.
DOI : 10.1172/JCI6560

R. Moqbel, F. Levi-schaffer, and A. Kay, Cytokine generation by eosinophils, Journal of Allergy and Clinical Immunology, vol.94, issue.6, pp.1183-1188, 1994.
DOI : 10.1016/0091-6749(94)90330-1

S. Nadarajah, B. Krafchik, C. Roifman, and C. Horgan-bell, Treatment of Hypereosinophilic Syndrome in a Child Using Cyclosporine: Implication for a Primary T-cell Abnormality, PEDIATRICS, vol.99, issue.4, pp.630-633, 1997.
DOI : 10.1542/peds.99.4.630

A. Pardanani, T. Reeder, L. Porrata, C. Li, H. Tazelaar et al., Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders, Blood, vol.101, issue.9, pp.3391-3397, 2003.
DOI : 10.1182/blood-2002-10-3103

K. Pazdrak, B. Olszewska-pazdrak, S. Stafford, R. Garofalo, and R. Alam, Lyn, Jak2, and Raf-1 Kinases Are Critical for the Antiapoptotic Effect of Interleukin 5, whereas only Raf-1 Kinase Is Essential for Eosinophil Activation and Degranulation, The Journal of Experimental Medicine, vol.152, issue.3, pp.421-429, 1998.
DOI : 10.1084/jem.180.6.2101

C. Phillips, W. Coward, D. Pritchard, and C. Hewitt, Basophils express a type 2 cytokine profile on exposure to proteases from helminths and house dust mites, Journal of Leukocyte Biology, vol.73, issue.1, pp.165-171, 2003.
DOI : 10.1189/jlb.0702356

V. Pitini, D. Teti, C. Arrigo, and M. Righi, Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome with abnormal T cells: a case report, British Journal of Haematology, vol.127, issue.5, p.477, 2004.
DOI : 10.1111/j.1365-2141.2004.05206.x

J. Ring, Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis, N Engl J Med, vol.349, pp.2334-2339, 2003.

M. Ravoet, C. Sibille, F. Roufosse, H. Duvillier, C. Sotiriou et al., 6q-is an early and persistent chromosomal aberration in, pp.3-4, 2005.

M. Rothenberg, Eosinophilia, N Engl J Med, vol.338, pp.1592-1600, 1998.

M. Rothenberg and S. Hogan, THE EOSINOPHIL, Annual Review of Immunology, vol.24, issue.1, pp.147-174, 2006.
DOI : 10.1146/annurev.immunol.24.021605.090720

M. Rothenberg, J. Maclean, E. Pearlman, A. Luster, and P. Leder, Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia, The Journal of Experimental Medicine, vol.99, issue.4, pp.785-790, 1997.
DOI : 10.1084/jem.183.1.195

F. Roufosse, E. Cogan, and M. Goldman, The Hypereosinophilic Syndrome Revisited, Annual Review of Medicine, vol.54, issue.1, pp.169-184, 2003.
DOI : 10.1146/annurev.med.54.101601.152431

C. Sanderson, Interleukin-5, eosinophils, and disease, Blood, vol.79, pp.3101-3109, 1992.

M. Goldman, Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells, J Clin Invest, vol.97, pp.309-315, 1996.

L. Schandene, F. Roufosse, A. De-lavareille, P. Stordeur, A. Efira et al., Interferon alpha prevents spontaneous apoptosis of clonal Th2 cells associated with chronic hypereosinophilia, Blood, vol.96, pp.4285-4292, 2000.

C. Scully, The Oral Cavity, In: Champion RH, 1992.

/. Rook and . Wilkinson, Ebling's Textbook of Dermatology, p.2709

C. Scully, The Oral Cavity, In: Champion RH, 1992.

/. Rook and . Wilkinson, Ebling's Textbook of Dermatology, p.2698

A. Sefcick, D. Sowter, E. Dasgupta, N. Russell, and J. Byrne, Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome, British Journal of Haematology, vol.15, issue.4, pp.558-559, 2004.
DOI : 10.1056/NEJMoa025217

D. Simon, L. Braathen, and H. Simon, Anti-Interleukin-5 Antibody Therapy in Eosinophilic Diseases, Pathobiology, vol.72, issue.6, pp.287-292, 2005.
DOI : 10.1159/000091326

H. Simon, S. Plotz, R. Dummer, and K. Blaser, Abnormal Clones of T Cells Producing Interleukin-5 in Idiopathic Eosinophilia, New England Journal of Medicine, vol.341, issue.15, pp.1112-1120, 1999.
DOI : 10.1056/NEJM199910073411503

S. Sutton and M. Rothenberg, Anti-IL-5 and hypereosinophilic syndromes, Clinical Immunology, vol.115, issue.1, 2005.
DOI : 10.1016/j.clim.2005.02.006

T. Matsui, Chronic eosinophilic leukemia with the FIP1L1-PDGFRalpha fusion gene in a patient with a history of combination chemotherapy, Int J Hematol, vol.83, pp.152-155, 2006.

T. Tauchi and K. Ohyashiki, The Second Generation of BCR-ABL Tyrosine Kinase Inhibitors, International Journal of Hematology, vol.83, issue.4, 2006.
DOI : 10.1532/IJH97.06025

S. Till, R. Dickason, D. Huston, M. Humbert, D. Robinson et al., IL-5 secretion by allergen-stimulated CD4+ T cells in primary culture: Relationship to expression of allergic disease, Journal of Allergy and Clinical Immunology, vol.99, issue.4, pp.563-569, 1997.
DOI : 10.1016/S0091-6749(97)70085-X

I. Tillie-leblond, P. Gosset, A. Janin, F. Salez, L. Prin et al., Increased interleukin-6 production during the acute phase of the syndrome of episodic angioedema and hypereosinophilia, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, vol.99, issue.97, pp.491-496, 1998.
DOI : 10.1016/0167-5699(90)90173-7

A. Tsicopoulos, A. Janin, H. Akoum, C. Lamblin, H. Vorng et al., Cytokine profile in minor salivary glands from patients with bronchial asthma, Journal of Allergy and Clinical Immunology, vol.106, issue.4, pp.687-696, 2000.
DOI : 10.1067/mai.2000.109826

L. Zoubarovskaya, E. Semenova, B. Afanasyev, O. Brien, and S. , Successful non-myeloablative allogeneic transplantation for treatment of idiopathic hypereosinophilic syndrome, Br J Haematol, vol.119, pp.131-134, 2002.

N. Ueno, S. Zhao, L. Robertson, U. Consoli, and M. Andreeff, 2-Chlorodeoxyadenosine therapy for idiopathic hypereosinophilic syndrome, Leukemia, vol.11, issue.8, pp.1386-1390, 1997.
DOI : 10.1038/sj.leu.2400717

L. Vandezande, B. Wallaert, P. Desreumaux, A. Tsicopoulos, C. Lamblin et al., Interleukin-5 immunoreactivity and mRNA expression in gut mucosa from patients with food allergy, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, vol.158, issue.20, pp.652-659, 1999.
DOI : 10.1084/jem.182.6.1759

D. Varon, M. Wetzler, and A. Berrebi, Hypereosinophilic Syndrome Associated With Polycythemia Vera, Archives of Internal Medicine, vol.146, issue.7, pp.1440-1441, 1986.
DOI : 10.1001/archinte.1986.00360190232036

N. Wallen, H. Kita, D. Weiler, and G. Gleich, Glucocorticoids inhibit cytokine-mediated eosinophil survival, J Immunol, vol.147, pp.3490-3495, 1991.

A. Wardlaw, Molecular basis for selective eosinophil trafficking in asthma: A multistep paradigm?????????, Journal of Allergy and Clinical Immunology, vol.104, issue.5, pp.917-926, 1999.
DOI : 10.1016/S0091-6749(99)70069-2

P. Weller, Eosinophils: structure and functions, Current Opinion in Immunology, vol.6, issue.1, pp.85-90, 1994.
DOI : 10.1016/0952-7915(94)90038-8

P. Weller and G. Bubley, The Idiopathic Hypereosinophilic Syndrome, Archives of Dermatology, vol.132, issue.5, pp.2759-2779, 1994.
DOI : 10.1001/archderm.1996.03890290125019

H. Wilkins, M. Crane, K. Copeland, and W. Williams, Hypereosinophilic syndrome: An update, American Journal of Hematology, vol.103, issue.2, pp.148-157, 2005.
DOI : 10.1002/ajh.20423

T. Yoon, G. Ahn, and S. Chang, Complete Remission of Hypereosinophilic Syndrome after Interferon-?? Therapy: Report of a Case and Literature Review, The Journal of Dermatology, vol.129, issue.2, pp.110-115, 2000.
DOI : 10.1111/j.1346-8138.2000.tb02131.x

P. Zabel and M. Schlaak, Cyclosporin for hypereosinophilic syndrome, Annals of Hematology, vol.58, issue.6, pp.230-231, 1991.
DOI : 10.1007/BF01729838

N. Zimmermann, G. Hershey, P. Foster, and M. Rothenberg, Chemokines in asthma: cooperative interaction between chemokines and IL-13, J Allergy Clin Immunol, vol.111, pp.227-242, 2003.